Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001723128-19-000145

Options or other derivatives

  • Director acquired 36,028 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
George Jeffrey P. Director 2019-12-14 Grant or award · Restricted Stock Units +7,522 7,522 D
George Jeffrey P. Director 2019-12-14 Grant or award · Stock Option +28,506 28,506 D
Loading xslF345X03/wf-form4_157662264303996.xml…